Bayer Wins China Approval for Stroke-Prevention Drug in New Class
Bayer said China authorized asundexian to prevent recurrent stroke, making it the first approved drug in a new class of blood thinners.
By Adria CalatayudBayer said it received regulatory authorization to launch a drug to prevent recurrent stroke in China, winning the first approval for a new class of blood-thinning medicines.The German pharmaceutical group has been counting on the drug--which is known as asundexian and will be mar…